Investments in Marketable Securities (Details 1)
In Thousands, unless otherwise specified |
12 Months Ended | 12 Months Ended | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 31, 2013
USD ($)
|
Jan. 31, 2012
USD ($)
|
Jan. 31, 2011
USD ($)
|
Sep. 01, 2012
USD ($)
|
Sep. 01, 2012
EUR (€)
|
Sep. 01, 2009
USD ($)
|
Sep. 01, 2009
EUR (€)
|
Jan. 31, 2013
Fair Value, Inputs, Level 3 [Member]
USD ($)
|
Jan. 31, 2012
Fair Value, Inputs, Level 3 [Member]
USD ($)
|
Jan. 31, 2013
Accrued Contingent Consideration [Member]
Fair Value, Inputs, Level 3 [Member]
USD ($)
|
|||||||||||
Ending balance January 31, 2012 | $ 12,255 | [1] | $ 2,200 | [1] | € 1,700 | [1] | $ 1,000 | [1] | € 800 | [1] | $ 5,656 | [1] | $ 12,255 | [1] | $ 12,255 | |||||
Additional contingent earnout | 2,222 | |||||||||||||||||||
Contingency payments | (8,453) | |||||||||||||||||||
Change in fair value | 1,662 | 3,031 | 0 | 194 | ||||||||||||||||
Translation adjustment | (562) | |||||||||||||||||||
Ending balance January 31, 2013 | $ 5,656 | [1] | $ 12,255 | [1] | $ 2,200 | [1] | € 1,700 | [1] | $ 1,000 | [1] | € 800 | [1] | $ 5,656 | [1] | $ 12,255 | [1] | $ 5,656 | |||
|
X | ||||||||||
- Definition
The amount of additional contingent consideration earnout. No definition available.
|
X | ||||||||||
- Definition
The amount of business acquisition translation adjustment. No definition available.
|
X | ||||||||||
- Definition
The cash outflow associated with contingent consideration. No definition available.
|
X | ||||||||||
- Definition
Fair value, as of the acquisition date, of potential payments under the contingent consideration arrangement including cash and shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents the amount of any change, including any differences arising upon settlement, recognized during the reporting period in the value of a liability, arising from an item of contingent consideration, assumed in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|